Predictors of interstitial lung disease in early systemic sclerosis: A prospective longitudinal study of the GENISOS cohort

Arthritis Research and Therapy

Volumn 12, Issue , 2010, Pages

  Assassi, Shervin ^a,b   Sharif, Roozbeh ^a   Lasky, Robert E ^b   McNearney, Terry A ^c   Estrada Y Martin, Rosa M ^a   Draeger, Hilda ^d   Nair, Deepthi K ^a   Fritzler, Marvin J ^e   Reveille, John D ^a   Arnett, Frank C ^a   Mayes, Maureen D ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^e UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED RNA POLYMERASE III; DNA DIRECTED RNA POLYMERASE III ANTIBODY; DNA TOPOISOMERASE; DNA TOPOISOMERASE ANTIBODY; ENZYME ANTIBODY; FIBRILLARIN; FIBRILLARIN ANTIBODY; PROTEIN ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DISEASE SEVERITY ASSESSMENT; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HISPANIC; HUMAN; INTERSTITIAL LUNG DISEASE; LONGITUDINAL STUDY; LUNG ARTERY PRESSURE; LUNG FIBROSIS; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDSGER SEVERITY INDEX; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PROSPECTIVE STUDY; SMOKING; SURVIVAL RATE; SYSTEMIC SCLEROSIS; THORAX RADIOGRAPHY; TOTAL LUNG CAPACITY; DISEASE COURSE; FOLLOW UP; MIDDLE AGED; PATHOPHYSIOLOGY; VITAL CAPACITY;

ADULT; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; SCLERODERMA, SYSTEMIC; VITAL CAPACITY;

EID: 77956477550     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar3125     Document Type: Article

References (46)

1. Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, Medsger TA Jr, Lucas M, Michet CJ, Kuwana M, Yasuoka H, van den HF, Te BL, van Laar JM, Verbeet NL, Matucci-Cerinic M, Georgountzos A, Moutsopoulos HM: Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 2005, 118:2-10
2. Assassi S, Del JD, Sutter K, McNearney TA, Reveille JD, Karnavas A, Gourh P, Estrada YMR, Fischbach M, Arnett FC, Mayes MD: Clinical and genetic factors predictive of mortality in early systemic sclerosis. Arthritis Rheum 2009, 61:1403-1411
3. Keefe FJ, Brown GK, Wallston KA, Caldwell DS: Coping with rheumatoid arthritis pain: catastrophizing as a maladaptive strategy. Pain 1989, 37:51-56
4. Steen VD, Medsger TA: Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007, 66:940-944
5. Furst D, Khanna D, Matucci-Cerinic M, Clements P, Steen V, Pope J, Merkel P, Foeldvari I, Seibold J, Pittrow D, Polisson R, Strand V: Systemic sclerosis - continuing progress in developing clinical measures of response. J Rheumatol 2007, 34:1194-1200
6. Simeon CP, Armadans L, Fonollosa V, Solans R, Selva A, Villar M, Lima J, Vaque J, Vilardell M: Mortality and prognostic factors in Spanish patients with systemic sclerosis. Rheumatology (Oxford) 2003, 42:71-75
7. Steen VD, Conte C, Owens GR, Medsger TA Jr: Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum 1994, 37:1283-1289
8. Colp CR, Riker J, Williams MH Jr: Serial changes in scleroderma and idiopathic interstitial lung disease. Arch Intern Med 1973, 132:506-515
9. Schneider PD, Wise RA, Hochberg MC, Wigley FM: Serial pulmonary function in systemic sclerosis. Am J Med 1982, 73:385-394
10. Morgan C, Knight C, Lunt M, Black CM, Silman AJ: Predictors of end stage lung disease in a cohort of patients with scleroderma. Ann Rheum Dis 2003, 62:146-150
11. Catoggio LJ, Bernstein RM, Black CM, Hughes GR, Maddison PJ: Serological markers in progressive systemic sclerosis: clinical correlations. Ann Rheum Dis 1983, 42:23-27
12. Steen VD, Owens GR, Fino GJ, Rodnan GP, Medsger TA Jr: Pulmonary involvement in systemic sclerosis (scleroderma). Arthritis Rheum 1985, 28:759-767
13. Steen VD: Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 2005, 35:35-42
14. Jacobsen S, Halberg P, Ullman S, Hoier-Madsen M, Petersen J, Mortensen J, Wiik A: A longitudinal study of pulmonary function in Danish patients with systemic sclerosis. Clin Rheumatol 1997, 16:384-390
15. Greidinger EL, Flaherty KT, White B, Rosen A, Wigley FM, Wise RA: African- American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease. Chest 1998, 114:801-807
16. Plastiras SC, Karadimitrakis SP, Ziakas PD, Vlachoyiannopoulos PG, Moutsopoulos HM, Tzelepis GE: Scleroderma lung: initial forced vital capacity as predictor of pulmonary function decline. Arthritis Rheum 2006, 55:598-602
17. Gilson M, Zerkak D, WipffJ, Dusser D, nh-Xuan AT, Abitbol V, Chaussade S, Legmann P, Kahan A, Allanore Y: Prognostic factors for lung function in systemic sclerosis: prospective study of 105 cases. Eur Respir J 2010, 35:112-117
18. McNearney TA, Reveille JD, Fischbach M, Friedman AW, Lisse JR, Goel N, Tan FK, Zhou X, Ahn C, Feghali-Bostwick CA, Fritzler M, Arnett FC, Mayes MD: Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors. Arthritis Rheum 2007, 57:318-326
19. Peters-Golden M, Wise RA, Schneider P, Hochberg M, Stevens MB, Wigley F: Clinical and demographic predictors of loss of pulmonary function in systemic sclerosis. Medicine (Baltimore) 1984, 63:221-231
20. Greenwald GI, Tashkin DP, Gong H, Simmons M, Duann S, Furst DE, Clements P: Longitudinal changes in lung function and respiratory symptoms in progressive systemic sclerosis. Prospective study. Am J Med 1987, 83:83-92
21. Tashkin DP, Clements PJ, Wright RS, Gong H Jr, Simmons MS, Lachenbruch PA, Furst DE: Interrelationships between pulmonary and extrapulmonary involvement in systemic sclerosis. A longitudinal analysis. Chest 1994, 105:489-495
22. Goh NS, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM, Corte TJ, Sander CR, RatoffJ, Devaraj A, Bozovic G, Denton CP, Black CM, du Bois RM, Wells AU: Interstitial lung disease in systemic sclerosis: a simple staging system. Am J Respir Crit Care Med 2008, 177:1248-1254
23. Abramson MJ, Barnett AJ, Littlejohn GO, Smith MM, Hall S: Lung function abnormalities and decline of spirometry in scleroderma: an overrated danger? Postgrad Med J 1991, 67:632-637
24. Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, Weinstein A, Weisman M, Mayes M, Collier D: Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995, 22:1281-1285
25. Reveille JD, Fischbach M, McNearney T, Friedman AW, Aguilar MB, Lisse J, Fritzler MJ, Ahn C, Arnett FC: Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants. Semin Arthritis Rheum 2001, 30:332-346
26. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma) [abstract]. Arthritis Rheum 1980, 23:581-590
27. Medsger TA Jr, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA, Harris CA, Jablonska S, Jayson MI, Jimenez SA, Krieg T, Leroy EC, Maddison PJ, Russell ML, Schachter RK, Wollheim FA, Zacharaie H: A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 1999, 26:2159-2167
28. Arnett FC, Reveille JD, Goldstein R, Pollard KM, Leaird K, Smith EA, Leroy EC, Fritzler MJ: Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis. Arthritis Rheum 1996, 39:1151-1160
29. Cotes JE, Dabbs JM, Elwood PC, Hall AM, McDonald A, Saunders MJ: Irondeficiency anaemia: its effect on transfer factor for the lung (diffusiong capacity) and ventilation and cardiac frequency during sub-maximal exercise. Clin Sci 1972, 42:325-335
30. Macintyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, Burgos F, Casaburi R, Coates A, Enright P, Gustafsson P, Hankinson J, Jensen R, McKay R, Miller MR, Navajas D, Pedersen OF, Pellegrino R, Wanger J: Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005, 26:720-735
31. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, Macintyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J: Standardisation of spirometry. Eur Respir J 2005, 26:319-338
32. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, Casaburi R, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Hankinson J, Jensen R, Johnson D, Macintyre N, McKay R, Miller MR, Navajas D, Pellegrino R, Viegi G: Standardisation of the measurement of lung volumes. Eur Respir J 2005, 26:511-522
33. Leroy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F: Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988, 15:202-205
34. Steen VD, Powell DL, Medsger TA Jr: Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 1988, 31:196-203
35. Okano Y, Steen VD, Medsger TA Jr: Autoantibody reactive with RNA polymerase III in systemic sclerosis. Ann Intern Med 1993, 119:1005-1013
36. Assassi S, Fritzler MJ, Arnett FC, Norman GL, Shah KR, Gourh P, Manek N, Perry M, Ganesh D, Rahbar MH, Mayes MD: Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients. J Rheumatol 2009, 36:2250-2256
37. Nietert PJ, Silver RM, Mitchell HC, Shaftman SR, Tilley BC: Demographic and clinical factors associated with in-hospital death among patients with systemic sclerosis. J Rheumatol 2005, 32:1888-1892
38. Mendoza F, Derk CT: Systemic sclerosis mortality in the United States: 1999-2002 implications for patient care. J Clin Rheumatol 2007, 13:187-192
39. Krishnan E, Furst DE: Systemic sclerosis mortality in the United States: 1979-1998. Eur J Epidemiol 2005, 20:855-861
40. Khanna D, Farmani N, Chi-Hong T, Clements PJ, Tashkin D, Roth M, Furst DE: Course of lung physiology in patients with scleroderma and active interstitial lung disease: results from the Scleroderma Lung Study [abstract]. Arthritis Rheum 2009, 6:S226
41. Tashkin DP, ElashoffR, Clements PJ, Goldin J, Roth MD, Furst DE, Arriola E, Silver R, Strange C, Bolster M, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel DE, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, et al: Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 2006, 354:2655-2666
42. Savarino E, Bazzica M, Zentilin P, Pohl D, Parodi A, Cittadini G, Negrini S, Indiveri F, Tutuian R, Savarino V, Ghio M: Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring. Am J Respir Crit Care Med 2009, 179:408-413
43. Dieude P, Guedj M, WipffJ, Avouac J, Fajardy I, Diot E, Granel B, Sibilia J, Cabane J, Mouthon L, Cracowski JL, Carpentier PH, Hachulla E, Meyer O, Kahan A, Boileau C, Allanore Y: Association between the IRF5 rs2004640 functional polymorphism and systemic sclerosis: a new perspective for pulmonary fibrosis. Arthritis Rheum 2009, 60:225-233
44. Asano Y, Ihn H, Yamane K, Yazawa N, Kubo M, Fujimoto M, Tamaki K: Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis. Arthritis Rheum 2001, 44:1363-1369
45. Hant FN, Ludwicka-Bradley A, Wang HJ, Li N, ElashoffR, Tashkin DP, Silver RM: Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma. J Rheumatol 2009, 36:773-780
46. Latsi PI, Wells AU: Evaluation and management of alveolitis and interstitial lung disease in scleroderma. Curr Opin Rheumatol 2003, 15:748-755